Literature DB >> 27906630

Evaluation of purine utilization by Lactobacillus gasseri strains with potential to decrease the absorption of food-derived purines in the human intestine.

N Yamada1,2, C Iwamoto1,2, H Kano1,2, N Yamaoka2, T Fukuuchi2, K Kaneko2, Y Asami1.   

Abstract

It is well accepted that frequent and heavy intake of purine-rich foods causes elevation of serum uric acid levels, which is a risk factor of hyperuricemia. Reducing intestinal absorption of dietary purines may attenuate the elevation of serum uric acid levels and exacerbation of hyperuricemia. This reduction may be achieved by the ingestion of lactic acid bacteria that take up purines in the intestine. In this study, we investigated the degree of uptake and utilization of purines of three lactobacilli strains. Among them, Lactobacillus gasseri PA-3 (PA-3) showed the greatest incorporation of 14C-adenine. PA-3 also incorporated 14C-adenosine and 14C-AMP. Additionally, using defined growth medium, PA-3 demonstrated greater proliferation in the presence of these purines than in their absence. Although further investigation is required, ingestion of PA-3 may lower serum uric acid levels by reducing intestinal absorption of purines in humans.

Entities:  

Keywords:  Lactobacillus gasseri PA-3; lactic acid bacteria; uptake of purines

Mesh:

Substances:

Year:  2016        PMID: 27906630     DOI: 10.1080/15257770.2015.1125000

Source DB:  PubMed          Journal:  Nucleosides Nucleotides Nucleic Acids        ISSN: 1525-7770            Impact factor:   1.381


  11 in total

Review 1.  The Interaction Between Dietary Fructose and Gut Microbiota in Hyperuricemia and Gout.

Authors:  Xin-Yu Fang; Liang-Wei Qi; Hai-Feng Chen; Peng Gao; Qin Zhang; Rui-Xue Leng; Yin-Guang Fan; Bao-Zhu Li; Hai-Feng Pan; Dong-Qing Ye
Journal:  Front Nutr       Date:  2022-06-22

2.  Potential Probiotic Lacticaseibacillus paracasei MJM60396 Prevents Hyperuricemia in a Multiple Way by Absorbing Purine, Suppressing Xanthine Oxidase and Regulating Urate Excretion in Mice.

Authors:  Youjin Lee; Pia Werlinger; Joo-Won Suh; Jinhua Cheng
Journal:  Microorganisms       Date:  2022-04-20

3.  Lactobacillus reuteri TSR332 and Lactobacillus fermentum TSF331 stabilize serum uric acid levels and prevent hyperuricemia in rats.

Authors:  Yi-Wei Kuo; Shih-Hung Hsieh; Jui-Fen Chen; Cheng-Ruei Liu; Ching-Wei Chen; Yu-Fen Huang; Hsieh-Hsun Ho
Journal:  PeerJ       Date:  2021-05-03       Impact factor: 2.984

Review 4.  The prospects of employing probiotics in combating COVID-19.

Authors:  Moutoshi Chakraborty; Saurab Kishore Munshi
Journal:  Tzu Chi Med J       Date:  2021-10-05

5.  Lactobacillus gasseri PA-3 Uses the Purines IMP, Inosine and Hypoxanthine and Reduces their Absorption in Rats.

Authors:  Naruomi Yamada; Chizuru Saito-Iwamoto; Marie Nakamura; Misato Soeda; Yoshika Chiba; Hiroshi Kano; Yukio Asami
Journal:  Microorganisms       Date:  2017-03-08

6.  Alterations of the Gut Microbiome Associated With the Treatment of Hyperuricaemia in Male Rats.

Authors:  Yiran Yu; Qiuping Liu; Haichang Li; Chengping Wen; Zhixing He
Journal:  Front Microbiol       Date:  2018-09-19       Impact factor: 5.640

Review 7.  Can Probiotics and Diet Promote Beneficial Immune Modulation and Purine Control in Coronavirus Infection?

Authors:  Ana H A Morais; Thais S Passos; Bruna L L Maciel; Juliana K da Silva-Maia
Journal:  Nutrients       Date:  2020-06-10       Impact factor: 5.717

8.  Effect of Lactobacillus gasseri PA3 on gut microbiota in an in vitro colonic simulation.

Authors:  Shasha Xiang; Jian Fu; Kun Ye; Yiqing Zheng; Xuan Zhu; Jie Chen; Yuewen Chen
Journal:  Food Sci Nutr       Date:  2019-11-14       Impact factor: 2.863

9.  A Multi-Omics Study of Chicken Infected by Nephropathogenic Infectious Bronchitis Virus.

Authors:  Puzhi Xu; Ping Liu; Changming Zhou; Yan Shi; Qingpeng Wu; Yitian Yang; Guyue Li; Guoliang Hu; Xiaoquan Guo
Journal:  Viruses       Date:  2019-11-16       Impact factor: 5.048

10.  Rhein modulates host purine metabolism in intestine through gut microbiota and ameliorates experimental colitis.

Authors:  Jiawei Wu; Zhonghong Wei; Peng Cheng; Cheng Qian; Fangming Xu; Yu Yang; Aiyun Wang; Wenxing Chen; Zhiguang Sun; Yin Lu
Journal:  Theranostics       Date:  2020-08-29       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.